drugset
drugset / Trial / NCT05934500

CBD Knee Scope Study

NCT05934500 ↗

Phase 0 Unknown 100 enrolled Foundation for Orthopaedic Research and Education
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications after a knee arthroscopy.

Timeline

Start
2023-10-15
Primary completion
2025-07-15
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 100 mg Oral
Subject Cannabidiol Other / unclassified 200 mg Oral

Indications

No indication recorded.